{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:24:02Z","timestamp":1783607042894,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006020","name":"Center for Translational Molecular Medicine","doi-asserted-by":"publisher","award":["041-201"],"award-info":[{"award-number":["041-201"]}],"id":[{"id":"10.13039\/501100006020","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2261-0","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T08:41:02Z","timestamp":1545122462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study"],"prefix":"10.1186","volume":"22","author":[{"name":"on behalf of the MARS consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-7630","authenticated-orcid":false,"given":"Kirsten","family":"van de Groep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf L.","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Peelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M. C.","family":"Klein Klouwenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Erik","family":"Hack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van der Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J. M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S. Y.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"2261_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jcrc.2014.10.002","volume":"30","author":"FG Frantzeskaki","year":"2015","unstructured":"Frantzeskaki FG, Karampi ES, Kottaridi C, Alepaki M, Routsi C, Tzanela M, et al. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers. J Crit Care. 2015;30:276\u201381.","journal-title":"J Crit Care"},{"key":"2261_CR2","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1186\/cc10069","volume":"15","author":"A Heininger","year":"2011","unstructured":"Heininger A, Haeberle H, Fischer I, Beck R, Riessen R, Rohde F, et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care. 2011;15:R77.","journal-title":"Crit Care"},{"key":"2261_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.2008.697","volume":"300","author":"AP Limaye","year":"2008","unstructured":"Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413\u201322.","journal-title":"JAMA"},{"key":"2261_CR4","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/CCM.0b013e3181a3aa43","volume":"37","author":"AC Kalil","year":"2009","unstructured":"Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med. 2009;37:2350\u20138.","journal-title":"Crit Care Med"},{"key":"2261_CR5","doi-asserted-by":"publisher","first-page":"ofx029","DOI":"10.1093\/ofid\/ofx029","volume":"4","author":"P Lachance","year":"2017","unstructured":"Lachance P, Chen J, Featherstone R, Sligl WI. Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis. Open Forum Infect Dis. 2017;4:ofx029.","journal-title":"Open Forum Infect Dis"},{"key":"2261_CR6","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/cc7875","volume":"13","author":"R Osawa","year":"2009","unstructured":"Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care. 2009;13:R68.","journal-title":"Crit Care"},{"key":"2261_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00134-015-4071-z","volume":"42","author":"DS Ong","year":"2016","unstructured":"Ong DS, Spitoni C, Klein Klouwenberg PM, Verduyn Lunel FM, Frencken JF, Schultz MJ, et al. Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome. Intensive Care Med 2016;42:333\u2013341.","journal-title":"Intensive Care Med"},{"key":"2261_CR8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/cid\/cix120","volume":"64","author":"DSY Ong","year":"2017","unstructured":"Ong DSY, Bonten MJM, Spitoni C, Verduyn Lunel FM, Frencken JF, Horn J, et al. Epidemiology of Multiple Herpes Viremia in Previously Immunocompetent Patients With Septic Shock. Clin Infect Dis. 2017;64:1204\u201310.","journal-title":"Clin Infect Dis"},{"key":"2261_CR9","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1097\/CCM.0b013e31819ffea6","volume":"37","author":"L Chiche","year":"2009","unstructured":"Chiche L, Forel JM, Roch A, Guervilly C, Pauly V, Allardet-Servent J, et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med. 2009;37:1850\u20137.","journal-title":"Crit Care Med"},{"key":"2261_CR10","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1097\/CCM.0b013e318260c90e","volume":"40","author":"L Chiche","year":"2012","unstructured":"Chiche L, Forel JM, Thomas G, Farnarier C, Cognet C, Guervilly C, et al. Interferon-gamma production by natural killer cells and cytomegalovirus in critically ill patients. Crit Care Med. 2012;40:3162\u20139.","journal-title":"Crit Care Med"},{"key":"2261_CR11","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/jmv.23621","volume":"85","author":"MA Clari","year":"2013","unstructured":"Clari MA, Aguilar G, Benet I, Belda J, Gimenez E, Bravo D, et al. Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients. J Med Virol. 2013;85:1802\u201310.","journal-title":"J Med Virol"},{"key":"2261_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00003246-200103000-00012","volume":"29","author":"A Heininger","year":"2001","unstructured":"Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med. 2001;29:541\u20137.","journal-title":"Crit Care Med"},{"key":"2261_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00134-015-4066-9","volume":"42","author":"L Papazian","year":"2016","unstructured":"Papazian L, Hraiech S, Lehingue S, Roch A, Chiche L, Wiramus S, Forel JM. Cytomegalovirus reactivation in ICU patients. Intensive Care Med. 2016;42:28\u201337.","journal-title":"Intensive Care Med"},{"key":"2261_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","volume":"4","author":"MK Gandhi","year":"2004","unstructured":"Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4:725\u201338.","journal-title":"Lancet Infect Dis"},{"key":"2261_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.CCM.0000257325.88144.30","volume":"35","author":"L Papazian","year":"2007","unstructured":"Papazian L, Doddoli C, Chetaille B, Gernez Y, Thirion X, Roch A, et al. A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med. 2007;35:755\u201362.","journal-title":"Crit Care Med"},{"key":"2261_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/rmv.664","volume":"20","author":"AP Limaye","year":"2010","unstructured":"Limaye AP, Boeckh M. CMV in critically ill patients: pathogen or bystander? Rev Med Virol. 2010;20:372\u20139.","journal-title":"Rev Med Virol"},{"key":"2261_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2042-4280-2-6","volume":"2","author":"S Varani","year":"2011","unstructured":"Varani S, Landini MP. Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae. 2011;2:6.","journal-title":"Herpesviridae"},{"key":"2261_CR18","doi-asserted-by":"publisher","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","volume":"9","author":"AH Walton","year":"2014","unstructured":"Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, et al. Reactivation of multiple viruses in patients with sepsis. PLoS One. 2014;9:e98819.","journal-title":"PLoS One"},{"key":"2261_CR19","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1111\/j.1600-6143.2009.02824.x","volume":"9","author":"RB Freeman Jr","year":"2009","unstructured":"Freeman RB Jr. The \u2018indirect\u2019 effects of cytomegalovirus infection. Am J Transplant. 2009;9:2453\u20138.","journal-title":"Am J Transplant"},{"key":"2261_CR20","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/jmv.21825","volume":"82","author":"M Chilet","year":"2010","unstructured":"Chilet M, Aguilar G, Benet I, Belda J, Tormo N, Carbonell JA, et al. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol. 2010;82:1384\u201391.","journal-title":"J Med Virol"},{"key":"2261_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/jama.2017.10569","volume":"318","author":"AP Limaye","year":"2017","unstructured":"Limaye AP, Stapleton RD, Peng L, Gunn SR, Kimball LE, Hyzy R, et al. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial. JAMA. 2017;318:731\u201340.","journal-title":"JAMA"},{"key":"2261_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ymeth.2013.04.005","volume":"61","author":"GC Keustermans","year":"2013","unstructured":"Keustermans GC, Hoeks SB, Meerding JM, Prakken BJ, de Jager W. Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples. Methods. 2013;61:10\u20137.","journal-title":"Methods"},{"key":"2261_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cyto.2017.10.021","volume":"106","author":"RC Scholman","year":"2018","unstructured":"Scholman RC, Giovannone B, Hiddingh S, Meerding JM, Malvar Fernandez B, van Dijk MEA, et al. Effect of anticoagulants on 162 circulating immune related proteins in healthy subjects. Cytokine. 2018;106:114\u201324.","journal-title":"Cytokine"},{"key":"2261_CR24","doi-asserted-by":"publisher","first-page":"j3683","DOI":"10.1136\/bmj.j3683","volume":"358","author":"TJ Cole","year":"2017","unstructured":"Cole TJ, Altman DG. Statistics Notes: Percentage differences, symmetry, and natural logarithms. BMJ. 2017;358:j3683.","journal-title":"BMJ"},{"key":"2261_CR25","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E","volume":"16","author":"A Cnaan","year":"1997","unstructured":"Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16:2349\u201380.","journal-title":"Stat Med"},{"key":"2261_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.CCM.0000149854.61192.DC","volume":"33","author":"PE Parsons","year":"2005","unstructured":"Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33:1\u20136 discussion 230\u20132.","journal-title":"Crit Care Med"},{"key":"2261_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","volume":"20","author":"JC Marshall","year":"2014","unstructured":"Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20:195\u2013203.","journal-title":"Trends Mol Med"},{"key":"2261_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00134-018-5134-8","volume":"44","author":"HJ Grooth de","year":"2018","unstructured":"de Grooth HJ, Postema J, Loer SA, Parienti JJ, Oudemans-van Straaten HM, Girbes AR. Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates. Intensive Care Med. 2018;44:311\u201322.","journal-title":"Intensive Care Med"},{"key":"2261_CR29","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/jmv.22202","volume":"83","author":"J Blanquer","year":"2011","unstructured":"Blanquer J, Chilet M, Benet I, Aguilar G, Munoz-Cobo B, Tellez A, et al. Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients. J Med Virol. 2011;83:1966\u201371.","journal-title":"J Med Virol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2261-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2261-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2261-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T19:24:09Z","timestamp":1576610649000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2261-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2261"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2261-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional or national research committee (or both) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this study, an opt-out informed consent method was approved.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest related to the subject matter.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"348"}}